The body adapts, and weight loss may slow down or stop, even though the medication continues to work in other ways
What do you think the new generation of T2DM and weight loss drugs will be
One of the main brain regions affected by GLP-1 activity is the hypothalamus , which regulates hunger, thirst, body temperature, and emotions
Single-pathway therapies may be particularly susceptible to this variability if patients have specific defects in the targeted pathway
If you are concerned about cancer risk, discuss personal and family history with a healthcare professional rather than relying on general search results
The health consequences are also becoming harder to ignore: Several doctors told Business Insider in July that they've seen a sharp increase in patients on GLP-1 medications when they enter treatment for eating disorders